Published April 30, 2023
| Version v1
Journal article
Open
Improvement in solubility of BCS class II drug: Telmisartan
Creators
- 1. Associate professor; Department of Pharmaceutics, DY Patil university school of pharmacy, Mumbai, India.
- 2. Students; Department of Pharmaceutics, HK College of Pharmacy, Mumbai, India.
Description
Telmisartan is used in the treatment of Hypertension (high blood pressure), prevention of heart attacks, strokes and heart failure. It is an angiotensin II type -1 receptor antagonist. Telmisartan belongs to class II under biopharmaceutical classification system. Hence, the solubility is the main issue. To increase the oral absorption, telmisartan requires enhancement in solubility and dissolution. The present study was aimed to increase the solubility of telmisartan by various techniques such as complexation and Solid dispersion. The tablet formulation was prepared to enhance the solubility and dissolution and compared with the drug release profile of the marketed preparation.
Files
WJBPHS-2023-0195.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ffe36482807aadceee4d2fad1754fa28
|
1.2 MB | Preview Download |